Quzhou, 324302,
China
Zhejiang Huakang Pharmaceuticals Co. Technographics
Zhejiang Huakang Pharmaceuticals Co. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Zhejiang Huakang Pharmaceuticals Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1000 Zhejiang Huakang Pharmaceuticals Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Zhejiang Huakang Pharmaceuticals Co. has purchased the following applications: Alibaba Cloud DirectMail for Transactional Email in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Zhejiang Huakang Pharmaceuticals Co. is running and its propensity to invest more and deepen its relationship with Alibaba or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Zhejiang Huakang Pharmaceuticals Co. revenues, which have grown to $120.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Zhejiang Huakang Pharmaceuticals Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Zhejiang Huakang Pharmaceuticals Co. Tech Stack and Enterprise Applications
Zhejiang Huakang Pharmaceuticals Co. PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Alibaba | Legacy | Alibaba Cloud DirectMail | Transactional Email | PaaS | n/a | 2019 | 2019 |
In 2019 Zhejiang Huakang Pharmaceuticals Co. implemented Alibaba Cloud DirectMail as its Transactional Email provider. The implementation is publicly referenced on huakangpharma.com and is used to send web triggered transactional messages and customer facing notifications from the company website.
Technical configuration centered on standard Transactional Email capabilities of Alibaba Cloud DirectMail, including SMTP relay and REST API sending, template management with variable substitution for dynamic content, automated sends driven by web events, and delivery status tracking with bounce handling. The deployment included authenticated sending practices such as sender domain verification and DNS updates for SPF and DKIM to support deliverability and reputation management.
Operational coverage focused on customer communications workflows originating from the website and was managed by customer service and web operations teams. Governance activities emphasized template validation, staged rollout across web endpoints, and centralized monitoring of delivery and bounce reports. Alibaba Cloud DirectMail is the Transactional Email platform for Zhejiang Huakang Pharmaceuticals Co. to manage website triggered messaging and related operational workflows.
|
IT Decision Makers and Key Stakeholders at Zhejiang Huakang Pharmaceuticals Co.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Zhejiang Huakang Pharmaceuticals Co. Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||